Litcius/Paper detail

Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015–2021)

Patrik Olekšák, Eugenie Nepovimová, Žofia Chrienová, Kamil Musílek, Jiří Patočka, Kamil Kuča

2022European Journal of Medicinal Chemistry46 citationsDOIOpen Access PDF

Topics & Concepts

PI3K/AKT/mTOR pathwaymTORC2mTORC1Mechanistic target of rapamycinRPTORKinaseChemistryDiscovery and development of mTOR inhibitorsPharmacologyCancer researchSignal transductionBiologyBiochemistryPI3K/AKT/mTOR signaling in cancerCRISPR and Genetic EngineeringMast cells and histamine
Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015–2021) | Litcius